Richard L. Love, Director at CTI BIOPHARMA CORP (CTIC), sold 12,999 shares at $3.19 ($42K) on 2017-09-28, disclosed to the SEC on 2017-10-02.
Open-market sale of $42k CTIC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.19 | 4,000 | $13K | 30.6% |
| 2 | $3.19 | 700 | $2K | 5.4% |
| 3 | $3.20 | 2,747 | $9K | 21.1% |
| 4 | $3.21 | 1,000 | $3K | 7.7% |
| 5 | $3.22 | 600 | $2K | 4.6% |
| 6 | $3.23 | 1,675 |
| $5K |
| 13.0% |
| 7 | $3.23 | 1,600 | $5K | 12.4% |
| 8 | $3.24 | 477 | $2K | 3.7% |
| 9 | $3.25 | 200 | $650 | 1.6% |
| Total | $3.21 avg | 12,999 | $42K | 100% |
| Filing → |
| CTIC | SELL | 2015-10-01 | $20K | — | Filing → |
| PRXL | SELL | 2015-09-03 | $85K | — | Filing → |
| PRXL | SELL | 2015-05-18 | $325K | — | Filing → |